22 completed, 7 unknown, 3 terminated, 2 active not recruiting. 9 Not applicable, 8 Phase 3, 4 Phase 4, 1 Early Phase 1, 1 Phase 1.
Follow Latent Tuberculosis Infection: new trials by email Literature Review of Latent Tuberculosis Infection trials Research Report on Latent Tuberculosis Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevalence of Latent Tuberculosis Infection Among Hemodialysis Patients Tuberculin Skin Test (TST) - Latent Tuberculosis Infection, End Stage Renal Disease (ESRD) | Not yet recruiting | Sohag University | 200 | 2025-12-01 | 2025-10-07 | |
| Evaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis Infection Latent Tuberculosis Infection, Tuberculosis Infection, Latent | Enrolling by invitation | Queen Mary University of London | 250 | 2024-04-02 | 2026-02-20 | |
| Latent Tuberculosis Infection Screening Using QuantiFERON at Pre-Employment Assessment in Hospital Workers CHu Nice QuantiFERON-TB Gold Plus - Latent Tuberculosis Infection | Completed | Centre Hospitalier Universitaire de Nice | 1185 | 2024-04-01 | 2026-09-02 | |
| Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients QuantiFERON-TB Gold (QFT) test - Tuberculosis, Latent Tuberculosis Infection | Recruiting | Huashan Hospital | 31440 | 2023-09-01 | 2025-04-01 | |
| Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above Recombinant Mycobacterium Tuberculosis Fusion Protein, Purified Protein Derivative of Tuberculin - Latent Tuberculosis Infection | Phase 3 | Completed | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 780 | 2023-08-03 | 2026-04-30 |
| Clinical Trial of Mica Mycobacterium Vaccae for Injection - Latent Tuberculosis Infection | Phase 4 | Active not recruiting | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 6800 | 2023-04-19 | 2024-06-25 |
| Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein Recombinant Mycobacterium tuberculosis fusion protein for injection, TB-PPD was injected - Latent Tuberculosis Infection | Phase 4 | Completed | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 7500 | 2023-04-17 | 2024-09-19 |
| Prospective Quality Improvement Project for High-Risk Diabetes Patients enhanced interactive education - Diabetes Mellitus, Latent Tuberculosis Infection | Not applicable | Terminated | Taipei Medical University WanFang Hospital | 149 | 2021-07-29 | 2025-07-22 |
| Performance Evaluation of the VIDAS TB-IGRA Assay. Blood draw and IGRA test - Active Tuberculosis, Latent Tuberculosis Infection | Completed | BioMérieux | 2401 | 2019-12-05 | 2021-07-16 | |
| Risk of SDRs Under 3HP and 1HP Regimen for LTBI isoniazid and rifapentine - Latent Tuberculosis Infection | Phase 3 | Completed | National Taiwan University Hospital | 490 | 2019-09-24 | 2023-12-26 |
| Nurse-Led Community Health Worker Adherence Model in 3HP Delivery Among Homeless Adults at Risk for TB Infection and HIV Nurse-led Community Health Worker TBI (RN/CHW TBI) program - Latent Tuberculosis Infection | Not applicable | Completed | University of California, Irvine | 50 | 2019-01-24 | 2024-04-18 |
| Latent Tuberculosis in Type 2 Diabetes Rifapentine and Isoniazid for 3 months, Isoniazid (INH) daily for 9 months - Latent Tuberculosis Infection | Phase 4 | Active not recruiting | Taichung Veterans General Hospital | 552 | 2018-04-18 | 2025-03-13 |
| Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection Latent Tuberculosis Infection | Unknown | Hanyang University | 1000 | 2017-06-19 | 2017-10-18 | |
| Enhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and Treatment Latent Tuberculosis Infection program evaluation & diagnosis - Latent Tuberculosis Infection | Not applicable | Completed | McGill University | 24 | 2016-07-01 | 2020-02-21 |
| VDOT for Monitoring Adherence to LTBI Treatment Video Directly Observed Therapy, In-Person DOT - Tuberculosis, Latent Tuberculosis Infection | Not applicable | Completed | University of California, San Diego | 129 | 2016-03-08 | 2021-02-05 |
| Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection Latent Tuberculosis Infection | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 1 | 2014-08-15 | 2017-07-02 | |
| Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan Rifapentine and Isoniazid for 3 months, Isoniazid for 9 months - Latent Tuberculosis Infection | Phase 3 | Unknown | National Taiwan University Hospital | 283 | 2014-08-01 | 2016-12-15 |
| Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis Latent Tuberculosis Infection, Tuberculosis | Completed | Centers for Disease Control and Prevention | 21334 | 2012-10-01 | 2021-01-28 | |
| Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT Self Administered Therapy (SAT), SMS reminders, isoniazid and rifapentine - Latent Tuberculosis Infection | Phase 3 | Completed | Centers for Disease Control and Prevention | 1002 | 2012-09-01 | 2025-03-13 |
| TB mHealth Study - Use of Cell Phones to Improve Compliance in Patients on LTBI Treatment Cell phone text messages - Latent Tuberculosis Infection | Early Phase 1 | Unknown | University of British Columbia | 350 | 2012-04-01 | 2015-10-12 |
Showing 20 of 38. Sign in to see all of them.
Latent Tuberculosis (38) · Tuberculosis (20) · HIV Infections (3) · Acquired Immunodeficiency Syndrome (2) · Diabetes Mellitus (2) · Mycobacterium Infections (2) · Coinfection (1) · Directly Observed Therapy (1) · Disease (1) · Drug-Related Side Effects and Adverse Reactions (1) · Kidney Failure, Chronic (1) · Medication Adherence (1) · Opportunistic Infections (1) · Pneumonia (1)
Actinomycetales Infections (38) · Bacterial Infections (38) · Bacterial Infections and Mycoses (38) · Gram-Positive Bacterial Infections (38) · Infections (38) · Latent Infection (38) · Mycobacterium Infections (36) · Tuberculosis (18) · Urogenital Diseases (4) · Blood-Borne Infections (3) · Communicable Diseases (3) · Genital Diseases (3) · Immune System Diseases (3) · Immunologic Deficiency Syndromes (3) · Lentivirus Infections (3)
Isoniazid (10) · rifapentine (4) · Injections (2) · Rifampin (2) · Blood Specimen Collection (1) · Hematologic Tests (1) · Levofloxacin (1) · Tuberculin (1) · Tuberculin Test (1) · Vitamin A (1) · retinol palmitate (1)
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (3) · McGill University (3) · National Taiwan University Hospital (3) · Centers for Disease Control and Prevention (2) · Germans Trias i Pujol Hospital (2) · Archivel Farma S.L. (1) · Assistance Publique - Hôpitaux de Paris (1) · Assuta Hospital Systems (1) · BioMérieux (1) · Case Western Reserve University (1) · Centre Hospitalier Universitaire de Nice (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · Hanyang University (1) · Henry M. Jackson Foundation for the Advancement of Military Medicine (1) · Hospital Universitari de Bellvitge (1)
United States (7) · China (5) · South Africa (5) · Spain (5) · Taiwan (5) · Canada (4) · Benin (3) · Brazil (3) · France (3) · Ghana (3) · Indonesia (3) · South Korea (3) · Australia (2) · Guinea (2) · India (2)
Dick Menzies, MD (2) · Pere-Joan Cardona, MD, PhD (2) · Yi Mo, Master (2) · Adeline M Nyamathi, PhD (1) · Amanda Lopes (1) · Andrey S Borisov, MD, MPH (1) · Anna M Mandalakas, MD, PhD (1) · Anneke C Hesseling, MD, MS (1) · Charles Daley (1) · Christine Ho, MD (1) · Daniel Hoft (1) · David Pride (1)
PMID 31866327, PMID 32539440, PMID 32785709, PMID 36949623, PMID 20627913, PMID 21765072, PMID 23694948, PMID 24586912, PMID 24719431, PMID 24835842, PMID 25404412, PMID 26213798, PMID 29020191, PMID 29114781, PMID 29393655, PMID 29437940, PMID 29982223, PMID 30029896, PMID 30067928, PMID 30067931, PMID 30898826, PMID 31892518, PMID 33765453, PMID 34380979, PMID 34499863, PMID 34702229, PMID 36815322, PMID 38568690, PMID 38586588, PMID 38996972, PMID 40560769
2009 (1), R21MD012696 (1)